Ipilimumab vs Methylprednisolone
Ipilimumab vs Methylprednisolone: Overview
This comparison examines the pharmacological differences between Ipilimumab and Methylprednisolone.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Methylprednisolone: Intermediate-acting synthetic glucocorticoid.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Methylprednisolone — 18-36 hours.
Chemical Properties
Molecular Formula: Methylprednisolone — C22H30O5.
Molecular Weight: Methylprednisolone — 374.4710 g/mol.
Type: Ipilimumab — Antibody; Methylprednisolone — Small molecule.